$NVO
Izingqinamba zokuphepha ze-GLP-1 zishaya uNovo Nordisk — kufakwe amacala angaphezu kuka-90
Kusukela ngo-2025, sekufakwe ngaphezu kwamacala angama-90 ngokumelene noNovo Nordisk eNkantolo Yombuso yaseNew Jersey ngenxa ye-semaglutide, isithako esisebenzayo emithini yayo yesifo sikashukela neyokunciphisa isisindo. Abamangalelwa bathi bahlaselwe i-NAION (non-arteritic anterior ischemic optic neuropathy) — isimo esingabangela ukulahleka kombono ngokuzumayo — ngemuva kokusebenzisa inguqulo yesifo sikashukela ye-semaglutide.
I-NVO yehlile ngo-4.86% kulandela ukunakwa okusha kule nkinga yokuphepha.
Kungani lokhu kuphawuleka: Imithi ye-GLP-1 (i-Ozempic, i-Wegovy, nokunye okufanayo) kube ngenye yezindaba zokukhula ezinkulu kakhulu eminyakeni embalwa edlule. Isigaba sokumangalelana esinjengalesi — noma ngaphambi kokuba kube khona izinqumo zenkantolo — sivame ukuthinta umuzwa futhi siphakamise imibuzo mayelana nobungozi besikhathi eside bokulawula nokuzibophezela hhayi nje inkampani eyodwa.
Okufanele kubhekwe: ukuthi ngabe abamangali abaningi bajoyina yini la macala, nokuthi uNovo Nordisk uzophendula kanjani — zombili cishe zizokwenza kube nomthelela ekuhambeni kwentengo okuseduze.
$NVO #Pharma #Novo #StockMarket
Izingqinamba zokuphepha ze-GLP-1 zishaya uNovo Nordisk — kufakwe amacala angaphezu kuka-90
Kusukela ngo-2025, sekufakwe ngaphezu kwamacala angama-90 ngokumelene noNovo Nordisk eNkantolo Yombuso yaseNew Jersey ngenxa ye-semaglutide, isithako esisebenzayo emithini yayo yesifo sikashukela neyokunciphisa isisindo. Abamangalelwa bathi bahlaselwe i-NAION (non-arteritic anterior ischemic optic neuropathy) — isimo esingabangela ukulahleka kombono ngokuzumayo — ngemuva kokusebenzisa inguqulo yesifo sikashukela ye-semaglutide.
I-NVO yehlile ngo-4.86% kulandela ukunakwa okusha kule nkinga yokuphepha.
Kungani lokhu kuphawuleka: Imithi ye-GLP-1 (i-Ozempic, i-Wegovy, nokunye okufanayo) kube ngenye yezindaba zokukhula ezinkulu kakhulu eminyakeni embalwa edlule. Isigaba sokumangalelana esinjengalesi — noma ngaphambi kokuba kube khona izinqumo zenkantolo — sivame ukuthinta umuzwa futhi siphakamise imibuzo mayelana nobungozi besikhathi eside bokulawula nokuzibophezela hhayi nje inkampani eyodwa.
Okufanele kubhekwe: ukuthi ngabe abamangali abaningi bajoyina yini la macala, nokuthi uNovo Nordisk uzophendula kanjani — zombili cishe zizokwenza kube nomthelela ekuhambeni kwentengo okuseduze.
$NVO #Pharma #Novo #StockMarket
